Prednicson versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Commentary on:Lancet 378,2011,338-346

Abstract

Tamoxifen, prednisone, retroperitoneal fibrosis, autoimmunity, radiotheraphy, sarkoidosis, systemmic lupus erythematodes, relaps, monitoring, chronical fibrosis, histiocyty

Keywords

• Tamoxifen, prednisone
• retroperitoneal fibrosis
• autoimmunity